Skip to main content

Table 4 Other clinical endpoints

From: Transcutaneous electrical acupoint stimulation improves pulmonary function by regulating oxidative stress during one-lung ventilation in patients with lung cancer undergoing thoracoscopic surgery: a randomized controlled trial

 

TEAS Group (n = 40)

Sham Group (n = 40)

P

Pleural effusion

11(27.5%)

13(32.5%)

0.626&

Atelectasis

2(5%)

7(17.5%)

0.157&

The duration of ICU stay (hours)

21.03 ± 6.92*

27.93 ± 12.42

0.003â–³

Thoracic drainage tube removal time (days)

3.44 ± 1.31

3.29 ± 1.21

0.597â–³

The length of postoperative hospitalization (days)

5.76 ± 1.35*

6.45 ± 1.66

0.046â–³

QoR-15 on postoperative day 1

114.33 ± 4.55*

111.70 ± 3.00

0.003â–³

QoR-15 on postoperative day 2

130.05 ± 3.88*

126.85 ± 4.25

0.001â–³

  1. Data are expressed as mean ± standard deviation or number of patients. *P < 0.05 versus sham group. △Student’s t-test, &Chi-square test. ICU: intensive care unit; QoR-15: Quality of Recovery-15; TEAS: transcutaneous electrical acupoint stimulation.